Sanofi Aventis Maps Out India R&D Strategy To Broaden Reach Into Untapped Markets

MUMBAI - For the last five years, the Indian affiliate of French drug giant Sanofi Aventis has been working very quietly, assiduously integrating the operations of the two companies that turned into a single entity as part of a mega-deal in 2004 and then drawing up its rollout program under the newly christened identity